Angiodynamics, Inc. (ANGO) Tops Q3 EPS by 1c; Guides Q4, FY12
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $15.62 -1.51%
EPS Growth %: -10.0%
Financial Fact:
Cost of sales: 43.07M
Today's EPS Names:
RCBC, GASS, YSG, More
EPS Growth %: -10.0%
Financial Fact:
Cost of sales: 43.07M
Today's EPS Names:
RCBC, GASS, YSG, More
Join SI Premium – FREE
Angiodynamics, Inc. (NASDAQ: ANGO) reported Q3 EPS of $0.09, $0.01 better than the analyst estimate of $0.08. Revenue for the quarter came in at $51.6 million versus the consensus estimate of $51.34 million.
Angiodynamics, Inc. sees FY2012 EPS of $0.42-$0.44, versus the consensus of $0.39. Angiodynamics, Inc. sees FY2012 revenue of $216.2-$218.2 million, versus the consensus of $216.5 million.
Angiodynamics, Inc. sees Q4 2012 EPS of $0.09-$0.11, versus the consensus of $0.10. Angiodynamics, Inc. sees Q4 2012 revenue of $52.1-$54.1 million, versus the consensus of $53.08 million.
For earnings history and earnings-related data on Angiodynamics, Inc. (ANGO) click here.
Angiodynamics, Inc. sees FY2012 EPS of $0.42-$0.44, versus the consensus of $0.39. Angiodynamics, Inc. sees FY2012 revenue of $216.2-$218.2 million, versus the consensus of $216.5 million.
Angiodynamics, Inc. sees Q4 2012 EPS of $0.09-$0.11, versus the consensus of $0.10. Angiodynamics, Inc. sees Q4 2012 revenue of $52.1-$54.1 million, versus the consensus of $53.08 million.
For earnings history and earnings-related data on Angiodynamics, Inc. (ANGO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Methode Electronics (MEI) Tops Q1 EPS by 2c; offers guidance
- Sprinklr (CXM) Tops Q2 EPS by 1c, Offers Guidance
- Five Below raises full-year outlook after strong second-quarter sales growth
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
